| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |